The Japan arm of Galderma Pharma S.A. transferred on August 1 its marketing authorization in Japan for the topical acne vulgaris treatment Epiduo Gel (adapalene + benzoyl peroxide) to Japanese dermatology powerhouse Maruho, the two companies said on the same…
To read the full story
Related Article
- Maruho Takes Over Differin Gel Marketing Authorization from Galderma
October 1, 2018
- Maruho, Galderma Team Up to Develop, Market Skin Treatments in Japan
January 19, 2016
BUSINESS
- Astellas Expands AI Drug Discovery to TPDs, Engineered Proteins
July 30, 2026
- Regeneron Japan Files First Dual-AAV Therapy for Genetic Hearing Loss
July 30, 2026
- Shionogi’s Xocova Debuts in US for COVID-19 PEP
July 30, 2026
- Some Drug Plants Halt Operations after Kumamoto Temblor, Supplies Unaffected
July 30, 2026
- Leqembi Global Sales Rise to 29.3 Billion Yen in April-June: Eisai
July 30, 2026
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…





